Sydney, 7 May 2013 – In an Australian first, after more than 10 years of research and development into the role of nutrition in Alzheimer’s disease, a breakthrough dietary approach to help manage the disease is now available.1,2 Souvenaid, a unique medical food that nutritionally supports memory function during the early stages of Alzheimer’s disease* is now available nation-wide, in the form of a new multi-nutrient drink.
Aussies can now access Souvenaid, the first ‘medical food’ nutritionally supporting memory function during the early stages of Alzheimer’s disease
According to Associate Professor Michael Woodward, Geriatrician and Director, Memory Clinic and Director, Aged Care Research, Melbourne, “The importance of nutrition and its role in helping to manage the early stages of Alzheimer’s disease cannot be underestimated. Medical nutrition is increasingly understood as a useful, and important, component in managing patient health. As such, I’m pleased to welcome the introduction of Souvenaid, as a new clinically proven nutritional management option for those living with mild Alzheimer’s disease.”
More than 320,000 Australians are currently living with dementia, a national health priority, and a staggering 1.2 million Australians are caregivers to a person living with dementia. Cases of dementia are expected to exceed 400,000 in the next 10 years and it is predicted to become the number one health issue in Australia this century if new treatments are not discovered.3 Alzheimer’s disease, the most common form of dementia affecting 50-70 per cent of cases, has no cure making the management of this condition hugely important, particularly given the predicted burden of disease.